Ledger.Open graph →
SEC Form D · filed December 5, 2022

Aspargo Laboratories, Inc

Offering
$15.0M
Sold
$290K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ENGLEWOOD CLIFFS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Michael Demurjian · Red Bank, NJExecMichael Rice · Englewood, NJDirectorPhilip M. De Bruyn · Dallas, TXDirectorHelios Capital Management LLC · Dover, DEExecFred Biehl · Roseland, NJDirectorRobert Zalewski · Oxford, MIExecFlow State Investments GP, LLC · Chicago, ILDirectorFred Biehl · Roseland, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗